Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease

Respirology

Volumn 14, Issue 8, 2009, Pages 1114-1120

  Tsimogianni, Angeliki M ^a   Papiris, Spyros A ^a   Kanavaki, Sofia ^b   Stathopoulos, Georgios T ^a   Sotiropoulou, Christina ^a   Manali, Effrosyni D ^a   Michalopoulou, Pinelopi ^b   Roussos, Charis ^a   Kotanidou, Anastasia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

Body mass index; Forced expiratory volume; Resource allocation; Respiratory tract infection; Sputum purulence

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN; CORTICOSTEROID;

ADULT; AGED; APACHE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPNEA; EMERGENCY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE PLANNING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SMOKING; SPUTUM CULTURE;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HUMANS; KLEBSIELLA; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 70350451904     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01615.x     Document Type: Article

References (33)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Lung Disease (GOLD) report updated November 2008. Accessed 11 June 2009 Available at: http://www.goldcopd. com/.
2. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 2007 29 : 1224 1238.
3. Connors AFJ, Dawson NV, Thomas C, Harrell FE, Desbiens N et al. Outcomes following acute exacerbation of severe chronic obstructive airways disease: the SUPPORT investigators. Am. J. Respir. Crit. Care Med. 1996 154 : 959 967.
4. Murphy T, Sethi S, Niederman M. The role of bacteria in exacerbations of COPD. Chest 2000 118 : 204 209.
5. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006 173 : 991 998.
6. Miravitlles M, Espinosa C, Fernandez-Lazo E, Martos JA, Maldonado JA et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 1999 116 : 40 6.
7. Balter M, La Forges J, Low D, Mandell L, Grossman R the Chronic Bronchitis Working Group. Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can. Respir. J. 2003 10 : 248 258. (Pubitemid 37192986)
8. Anonymous. BTS guidelines for the management if chronic obstructive pulmonary disease. The COPD Group of the Standards of Care Committee of the BTS. Thorax 1997 52 : S1 28.
9. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M et al. Guidelines for the management of adult lower respiratory tract infections. Eur. Respir. J. 2005 26 : 1138 1180.
10. Davies L, Hadcroft J, Mutton K, Earis JE, Kennedy N. Antimicrobial management of acute exacerbation of chronic airflow limitation. QJM 2001 94 : 373 378.
11. Van der Valk P, Monninkhof E, Van der Palen J, Zielhuis G, van Herwaarden C et al. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin. Infect. Dis. 2004 39 : 980 986.
12. Rossi N, Kouassi B, Rabbat A, Mounedji A, Lorut C et al. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Respiration 2007 74 : 19 25.
13. Lode H, Allewelt M, Balk S, De Roux A, Mauch H et al. A prediction model for bacterial etiology in acute exacerbations of COPD. Infection 2007 35 : 143 149.
14. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA et al. Guidelines for the management of adults with Community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 2001 163 : 1730 1754.
15. Soler N, Agusti C, Angrill J, Pugi De la Bellacasa J, Torres A. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 2007 62 : 29 35. (Pubitemid 46101763)
16. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest 2001 117 : 1638 1645.
17. Monso E, Garcia-Aymerich J, Soler N, Farrero E, Felez MA et al. Bacterial infection in exacerbated COPD with changes in sputum characteristics. Epidemiol. Infect. 2003 131 (1 799 804.
18. Fagon JY, Chastre J, Trouillet JL, Domart Y, Dombret MC et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am. Rev. Respir. Dis. 1990 142 : 1004 1008.
19. Ewig S, Soler N, Gonzalez J, Celis R, El-Ebiany M et al. Evaluation of antibiotic treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations. Crit. Care Med. 2000 28 : 692 697.
20. Celli B, Cote C, Mario J, Casanova C, Montes de Oca M et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004 350 : 1005 1012.
21. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW et al. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999 54 : 581 586.
22. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003 21 : 347 360.
23. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur. Respir. J. 2003 21 : 46s 53s.
24. Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ et al. Markers of exacerbation severity in chronic obstructive pulmonary disease. Respir. Res. 2006 7 : 74.
25. Goel A, Pinckney RG, Littenberg B. Apache II score predicts long-term survival in COPD patients admitted to a general medical ward. J. Gen. Intern. Med. 2003 18 : 824 830.
26. American Thoracic Society. Standardization of spirometry: 1994 update. Am. J. Respir. Crit. Care Med. 1995 152 : 1107 1136.
27. Barlett JC, Ryan KJ, Smith TF. Laboratory diagnosis of lower respiratory tract infections. In : Washington JA II. (ed.) Cumitech 7A. American Society for Microbiology, Washington, 1987 1 18.
28. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. National Committee for Clinical Laboratory Standardsand, Wayne, PA, 2002 2004 update M100 S114.
29. Russo RL, D' Aprile M. Role of antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease. Ann. Pharmacother. 2001 35 (5 576 581.
30. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B et al. Quality of care for patients hospitalised for acute exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 2006 144 (12 894 903.
31. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ et al. Airway inflammation and etiology of acute exacerbation of chronic bronchitits. Chest 2000 118 (6 1557 1565.
32. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC et al. Relationship between bacterial colonisation and the frequency, character and severity of COPD. Thorax 2002 57 : 759 764.
33. Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007 131 : 9 19.